Jeil Pharmaceutical Holding Overview

  • Year Founded
  • 1959

Year Founded

  • Status
  • Public

  • Employees
  • 38

Employees

  • Stock Symbol
  • 002620

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $4.97
  • (As of Friday Closing)

Jeil Pharmaceutical Holding General Information

Description

Jeil Pharma Holdings Inc is involved in manufacture and distribution of pharmaceutical products. The company mainly produces finished pharmaceutical products and active pharmaceutical ingredients. It has categorized its products in Antibiotic, Oncology, Cardiovascular, Gastrointestinal, Urology, Respiratory etc. The firm's manufacturing facility and research and development institute located at Yongin-si, Gyeonggi-do in Korea.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 343 Sapyeong-daero
  • Seocho-gu
  • Seoul, 06543
  • South Korea
+82
Primary Industry
Holding Companies
Other Industries
Pharmaceuticals
Stock Exchange
KRX
Corporate Office
  • 343 Sapyeong-daero
  • Seocho-gu
  • Seoul, 06543
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Jeil Pharmaceutical Holding Stock Performance

As of 20-Nov-2026, Jeil Pharmaceutical Holding’s stock price is $4.97. Its current market cap is $76.2M with 15.4M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.97 $5.11 $3.98 - $6.82 $76.2M 15.4M 4.58K $0.38

Jeil Pharmaceutical Holding Financials Summary

As of 30-Jun-2026, Jeil Pharmaceutical Holding has a trailing 12-month revenue of $435M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 218,879 252,643 222,500 291,099
Revenue 434,721 462,088 571,534 614,971
EBITDA 31,226 42,071 (29,566) 5,748
Net Income 5,812 10,284 (37,495) (12,429)
Total Assets 577,938 608,791 604,515 682,867
Total Debt 119,726 116,228 105,373 123,565
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Jeil Pharmaceutical Holding Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Jeil Pharmaceutical Holding‘s full profile, request access.

Request a free trial

Jeil Pharmaceutical Holding Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Jeil Pharmaceutical Holding Investments (3)

Jeil Pharmaceutical Holding’s most recent deal was a Later Stage VC with Autotelic Bio for . The deal was made on 14-Dec-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Autotelic Bio 14-Dec-2020 Later Stage VC Drug Discovery
Chongqing JeilYao Pharma 25-Sep-2013 Joint Venture Pharmaceuticals
Kyowa Hakko Kirin Korea 24-May-1991 Joint Venture Pharmaceuticals
To view Jeil Pharmaceutical Holding’s complete investments history, request access »

Jeil Pharmaceutical Holding ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Jeil Pharmaceutical Holding’s complete esg history, request access »

Jeil Pharmaceutical Holding Exits (1)

Jeil Pharmaceutical Holding’s most recent exit was on 24-May-1991 from Kyowa Hakko Kirin Korea. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Kyowa Hakko Kirin Korea 24-May-1991 Completed
  • 2 buyers
To view Jeil Pharmaceutical Holding’s complete exits history, request access »

Jeil Pharmaceutical Holding FAQs

  • When was Jeil Pharmaceutical Holding founded?

    Jeil Pharmaceutical Holding was founded in 1959.

  • Where is Jeil Pharmaceutical Holding headquartered?

    Jeil Pharmaceutical Holding is headquartered in Seoul, South Korea.

  • What is the size of Jeil Pharmaceutical Holding?

    Jeil Pharmaceutical Holding has 38 total employees.

  • What industry is Jeil Pharmaceutical Holding in?

    Jeil Pharmaceutical Holding’s primary industry is Holding Companies.

  • Is Jeil Pharmaceutical Holding a private or public company?

    Jeil Pharmaceutical Holding is a Public company.

  • What is Jeil Pharmaceutical Holding’s stock symbol?

    The ticker symbol for Jeil Pharmaceutical Holding is 002620.

  • What is the current stock price of Jeil Pharmaceutical Holding?

    As of 20-Nov-2026 the stock price of Jeil Pharmaceutical Holding is $4.97.

  • What is the current market cap of Jeil Pharmaceutical Holding?

    The current market capitalization of Jeil Pharmaceutical Holding is $76.2M.

  • What is Jeil Pharmaceutical Holding’s current revenue?

    The trailing twelve month revenue for Jeil Pharmaceutical Holding is $435M.

  • What is Jeil Pharmaceutical Holding’s annual earnings per share (EPS)?

    Jeil Pharmaceutical Holding’s EPS for 12 months was $0.38.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process